Novo Holdings A/s - Net Worth and Insider Trading

Novo Holdings A/s Net Worth

The estimated net worth of Novo Holdings A/s is at least $1.7 Billion dollars as of 2024-10-10. Novo Holdings A/s is the 10% Owner of Arcellx Inc and owns about 4,016,878 shares of Arcellx Inc (ACLX) stock worth over $333 Million. Novo Holdings A/s is the 10% Owner of Edgewise Therapeutics Inc and owns about 6,071,703 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $184 Million. Novo Holdings A/s is also the 10% Owner of Morphic Holding Inc and owns about 2,645,446 shares of Morphic Holding Inc (MORF) stock worth over $151 Million. Besides these, Novo Holdings A/s also holds Harmony Biosciences Holdings Inc (HRMY) , CoLucid Pharmaceuticals Inc (CLCD) , iRhythm Technologies Inc (IRTC) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , AnaptysBio Inc (ANAB) , Disc Medicine Inc (IRON) , Inogen Inc (INGN) , Checkmate Pharmaceuticals Inc (CMPI) , Flexion Therapeutics Inc (FLXN) , Apollo Endosurgery Inc (APEN) , Inozyme Pharma Inc (INZY) , Nkarta Inc (NKTX) , Cyteir Therapeutics Inc (CYTT) , Corvus Pharmaceuticals Inc (CRVS) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Milestone Pharmaceuticals Inc (MIST) , Verve Therapeutics Inc (VERV) , Metagenomi Inc (MGX) , Bolt Biotherapeutics Inc (BOLT) , Spruce Biosciences Inc (SPRB) , Aligos Therapeutics Inc (ALGS) , Galecto Inc (GLTO) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) . Details can be seen in Novo Holdings A/s's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Novo Holdings A/s has not made any transactions after 2024-07-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Novo Holdings A/s

To

Novo Holdings A/s Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Novo Holdings A/s owns 41 companies in total, including Praxis Precision Medicines Inc (PRAX) , Eargo Inc (EAR) , and Aligos Therapeutics Inc (ALGS) among others .

Click here to see the complete history of Novo Holdings A/s’s form 4 insider trades.

Insider Ownership Summary of Novo Holdings A/s

Ticker Comapny Transaction Date Type of Owner
PRAX Praxis Precision Medicines Inc 2020-10-15 10 percent owner
EAR Eargo Inc 2020-10-20 10 percent owner
ALGS Aligos Therapeutics Inc 2020-10-20 10 percent owner
LIMIT LIMIT 2021-02-18 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2024-03-21 10 percent owner
LIMIT LIMIT 2020-08-21 10 percent owner
LIMIT LIMIT 2022-02-25 10 percent owner
LIMIT LIMIT 2021-01-28 10 percent owner
LIMIT LIMIT 2020-07-14 10 percent owner
LIMIT LIMIT 2020-07-08 10 percent owner
LIMIT LIMIT 2019-11-25 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2019-07-22 10 percent owner
LIMIT LIMIT 2019-06-28 10 percent owner
LIMIT LIMIT 2018-09-28 10 percent owner
LIMIT LIMIT 2017-10-12 10 percent owner
LIMIT LIMIT 2017-08-25 10 percent owner
LIMIT LIMIT 2017-08-21 10 percent owner
LIMIT LIMIT 2017-07-26 10 percent owner
LIMIT LIMIT 2017-06-14 10 percent owner
LIMIT LIMIT 2016-12-15 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2016-10-31 10 percent owner
LIMIT LIMIT 2016-10-25 10 percent owner
LIMIT LIMIT 2016-09-09 10 percent owner
LIMIT LIMIT 2016-07-11 10 percent owner
LIMIT LIMIT 2015-06-22 10 percent owner
LIMIT LIMIT 2014-11-05 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2021-03-01 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2014-08-12 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2014-06-23 10 percent owner & other: See Remarks
LIMIT LIMIT 2014-05-13 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2014-03-19 10 percent owner & other: SEE REMARKS
LIMIT LIMIT 2021-10-26 10 percent owner
LIMIT LIMIT 2023-06-23 10 percent owner
LIMIT LIMIT 2022-07-13 10 percent owner
LIMIT LIMIT 2023-07-20 10 percent owner
LIMIT LIMIT 2022-09-14 10 percent owner
LIMIT LIMIT 2022-02-08 10 percent owner
LIMIT LIMIT 2020-11-02 10 percent owner
LIMIT LIMIT 2021-06-21 10 percent owner
LIMIT LIMIT 2024-07-26 10 percent owner
LIMIT LIMIT 2023-06-28 10 percent owner

Novo Holdings A/s Latest Holdings Summary

Novo Holdings A/s currently owns a total of 37 stocks. Among these stocks, Novo Holdings A/s owns 4,016,878 shares of Arcellx Inc (ACLX) as of February 8, 2022, with a value of $333 Million and a weighting of 19.33%. Novo Holdings A/s owns 6,071,703 shares of Edgewise Therapeutics Inc (EWTX) as of September 14, 2022, with a value of $184 Million and a weighting of 10.68%. Novo Holdings A/s also owns 2,645,446 shares of Morphic Holding Inc (MORF) as of June 28, 2019, with a value of $151 Million and a weighting of 8.75%. The other 34 stocks Harmony Biosciences Holdings Inc (HRMY) , CoLucid Pharmaceuticals Inc (CLCD) , iRhythm Technologies Inc (IRTC) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , AnaptysBio Inc (ANAB) , Disc Medicine Inc (IRON) , Inogen Inc (INGN) , Checkmate Pharmaceuticals Inc (CMPI) , Flexion Therapeutics Inc (FLXN) , Apollo Endosurgery Inc (APEN) , Inozyme Pharma Inc (INZY) , Nkarta Inc (NKTX) , Cyteir Therapeutics Inc (CYTT) , Corvus Pharmaceuticals Inc (CRVS) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Milestone Pharmaceuticals Inc (MIST) , Verve Therapeutics Inc (VERV) , Metagenomi Inc (MGX) , Bolt Biotherapeutics Inc (BOLT) , Spruce Biosciences Inc (SPRB) , Aligos Therapeutics Inc (ALGS) , Galecto Inc (GLTO) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) have a combined weighting of 61.24% among all his current holdings.

Latest Holdings of Novo Holdings A/s

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACLX Arcellx Inc 2022-02-08 4,016,878 82.96 333,240,199
EWTX Edgewise Therapeutics Inc 2022-09-14 6,071,703 30.33 184,154,752
MORF Morphic Holding Inc 2019-06-28 2,645,446 56.99 150,763,968
HRMY Harmony Biosciences Holdings Inc 2020-08-21 4,409,803 33.61 148,213,479
CLCD CoLucid Pharmaceuticals Inc 2016-09-09 3,156,563 46.53 146,859,094
IRTC iRhythm Technologies Inc 2016-10-25 2,124,448 58.67 124,641,364
RETA Reata Pharmaceuticals Inc 2017-06-14 592,794 172.36 102,173,974
RARX Ra Pharmaceuticals Inc 2016-10-31 2,031,562 47.99 97,494,660
MIRM Mirum Pharmaceuticals Inc 2019-07-22 2,445,147 37.85 92,548,814
TBRA Tobira Therapeutics Inc 2016-07-13 1,875,905 42.09 78,956,841
ANAB AnaptysBio Inc 2017-08-21 1,936,604 31.45 60,906,196
IRON Disc Medicine Inc 2023-06-28 1,090,772 46.77 51,015,406
INGN Inogen Inc 2021-03-01 2,759,320 9.00 24,833,880
CMPI Checkmate Pharmaceuticals Inc 2022-02-25 2,161,990 10.50 22,700,895
FLXN Flexion Therapeutics Inc 2015-06-22 2,133,131 9.12 19,454,155
APEN Apollo Endosurgery Inc 2017-07-26 1,301,842 10.00 13,018,420
INZY Inozyme Pharma Inc 2021-01-28 2,194,379 5.11 11,213,277
NKTX Nkarta Inc 2020-07-14 2,793,865 3.94 11,007,828
CYTT Cyteir Therapeutics Inc 2023-07-20 3,522,136 3.01 10,601,629
CRVS Corvus Pharmaceuticals Inc 2020-07-08 1,389,498 5.99 8,323,093
RPHM Reneo Pharmaceuticals Inc 2023-06-23 333,034 18.20 6,061,219
IOBT IO Biotech Inc 2024-07-26 4,354,449 1.10 4,789,894
ETTX Entasis Therapeutics Holdings Inc 2018-09-28 2,181,843 2.19 4,778,236
MIST Milestone Pharmaceuticals Inc 2019-11-25 2,434,470 1.50 3,651,705
VERV Verve Therapeutics Inc 2021-06-21 793,265 4.57 3,625,221
MGX Metagenomi Inc 2024-02-13 1,739,175 1.95 3,391,391
BOLT Bolt Biotherapeutics Inc 2022-07-13 3,703,991 0.64 2,370,554
SPRB Spruce Biosciences Inc 2024-03-21 2,550,000 0.43 1,083,750
ALGS Aligos Therapeutics Inc 2020-10-20 104,583 7.76 811,564
GLTO Galecto Inc 2020-11-02 99,912 7.16 715,370
GRTX Galera Therapeutics Inc 2021-02-18 2,459,021 0.07 181,968
EAR Eargo Inc 2020-10-20 44,354 2.57 113,990
UTRS Minerva Surgical Inc 2021-10-26 102,857 0.01 1,234
CMPI Cold Metal Products Inc 2020-08-11 2,170,100 0.00 0
KALV KalVista Pharmaceuticals Inc 2017-10-12 0 11.25 0
HTGMQ HTG Molecular Diagnostics Inc 2017-08-25 0 0.00 0
ISEE IVERIC bio Inc 2016-12-15 0 39.95 0

Holding Weightings of Novo Holdings A/s


Novo Holdings A/s Form 4 Trading Tracker

According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Arcellx Inc is the acquisition of 833,333 shares on February 8, 2022, which cost Novo Holdings A/s around $13 Million.

According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 2 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Edgewise Therapeutics Inc is the acquisition of 484,496 shares on September 14, 2022, which cost Novo Holdings A/s around $5 Million.

According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 0 transactions in Morphic Holding Inc (MORF) over the past 5 years. The most-recent trade in Morphic Holding Inc is the acquisition of 666,667 shares on June 28, 2019, which cost Novo Holdings A/s around $10 Million.

More details on Novo Holdings A/s's insider transactions can be found in the Insider Trading History of Novo Holdings A/s table.

Insider Trading History of Novo Holdings A/s

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Novo Holdings A/s Trading Performance

GuruFocus tracks the stock performance after each of Novo Holdings A/s's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Novo Holdings A/s is 3.33%. GuruFocus also compares Novo Holdings A/s's trading performance to market benchmark return within the same time period. The performance of stocks bought by Novo Holdings A/s within 3 months outperforms 15 times out of 37 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Novo Holdings A/s's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Novo Holdings A/s

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
12 out of 35 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.32 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Novo Holdings A/s Ownership Network

Ownership Network List of Novo Holdings A/s

No Data

Ownership Network Relation of Novo Holdings A/s

Insider Network Chart

Novo Holdings A/s Owned Company Details

What does Praxis Precision Medicines Inc do?

Who are the key executives at Praxis Precision Medicines Inc?

Novo Holdings A/s is the 10 percent owner of Praxis Precision Medicines Inc. Other key executives at Praxis Precision Medicines Inc include Chief Executive Officer Marcio Souza , Chief Financial Officer Timothy Edwin Kelly , and Principal Accounting Officer Lauren Mastrocola .

Praxis Precision Medicines Inc (PRAX) Insider Trades Summary

Over the past 18 months, Novo Holdings A/s made no insider transaction in Praxis Precision Medicines Inc (PRAX). Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 14,500 shares made by Jill Desimone , and a net purchase of 10,000 shares made by Marcio Souza .

In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 1,633 shares were bought by its insiders, resulting in a net purchase of 1,633 shares.

Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Praxis Precision Medicines Inc Insider Transactions

No Available Data

Novo Holdings A/s Mailing Address

Above is the net worth, insider trading, and ownership report for Novo Holdings A/s. You might contact Novo Holdings A/s via mailing address: Tuborg Havnevej 19, Hellerup G7 2900.

Discussions on Novo Holdings A/s

No discussions yet.